Oral Proteins and Peptides Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global oral proteins and peptides market is expected to grow at a CAGR of around 26.1% during 2025-2034. This report on global oral proteins and peptides market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global oral proteins and peptides market by segmenting the market based on drug type, product type, application, end user, and region. Also, detailed profiles of companies operating in the oral proteins and peptides market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Rise in Patient Preference for Oral Drugs
• Rising Demand for Effective Drugs and Product Type
Market Challenges
• High Cost
• Low Availability of the Product
Historical & Forecast Period
Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034
Market by Drug Type
• Linaclotide
• Plecanatide
• Calcitonin
• Insulin
• Octreotide
Market by Product Type
• Low Molecular Weight Iron Dextran
• Ferric Gluconate
• Iron Sucrose
• Ferric Carboxyl Maltose
Market by Application
• Gastric and Digestive Disorders
• Bone Diseases
• Diabetes
• Hormonal Disorders
• Others
Market by End User
• Hospital
• Pharmaceutical Company
• Others
Market by Region
• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa
- 1. Preface
- 1.1 Objective
- 1.2 Target Audience & Key Offerings
- 1.3 Report’s Scope
- 1.4 Research Methodology
- 1.4.1 Phase I
- 1.4.2 Phase II
- 1.4.3 Phase III
- 1.5 Assumptions
- 2. Key Insights
- 3. Global Oral Proteins and Peptides Market
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Challenges
- 4. Global Oral Proteins and Peptides Market Analysis
- 4.1. Market Portraiture
- 4.2. Market Size
- 4.3. Market Forecast
- 4.4. Impact of COVID-19
- 4.5. Impact of Russia-Ukraine War
- 5. Global Oral Proteins and Peptides Market by Drug Type
- 5.1. Introduction
- 5.2. Linaclotide
- 5.3. Plecanatide
- 5.4. Calcitonin
- 5.5. Insulin
- 5.6. Octreotide
- 6. Global Oral Proteins and Peptides Market by Product Type
- 6.1. Introduction
- 6.2. Low Molecular Weight Iron Dextran
- 6.3. Ferric Gluconate
- 6.4. Iron Sucrose
- 6.5. Ferric Carboxyl Maltose
- 7. Global Oral Proteins and Peptides Market by Application
- 7.1. Introduction
- 7.2. Gastric and Digestive Disorders
- 7.3. Bone Diseases
- 7.4. Diabetes
- 7.5. Hormonal Disorders
- 7.6. Others
- 8. Global Oral Proteins and Peptides Market by End User
- 8.1. Introduction
- 8.2. Hospital
- 8.3. Pharmaceutical Company
- 8.4. Others
- 9. Global Oral Proteins and Peptides Market by Region
- 9.1. Introduction
- 9.2. Europe
- 9.2.1. Germany
- 9.2.2. United Kingdom
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Russia
- 9.2.7. Netherlands
- 9.2.8. Rest of the Europe
- 9.3. North America
- 9.3.1. United States
- 9.3.2. Canada
- 9.4. Asia Pacific
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. India
- 9.4.4. South Korea
- 9.4.5. Australia
- 9.4.6. Indonesia
- 9.4.7. Rest of the Asia Pacific
- 9.5. Latin America
- 9.5.1. Mexico
- 9.5.2. Brazil
- 9.5.3. Argentina
- 9.5.4. Rest of Latin America
- 9.6. Middle East & Africa
- 9.6.1. Saudi Arabia
- 9.6.2. Turkey
- 9.6.3. Iran
- 9.6.4. United Arab Emirates
- 9.6.5. Rest of Middle East & Africa
- 10. SWOT Analysis
- 11. Porter’s Five Forces
- 12. Market Value Chain Analysis
- 13. Competitive Landscape
- 13.1. Competitive Scenario
- 13.2. Company Profiles
- 13.2.1. AbbVie Inc.
- 13.2.2. Allergan Plc.
- 13.2.3. AstraZeneca PLC
- 13.2.4. Bayer AG
- 13.2.5. Biocon Limited
- 13.2.6. Chiasma Inc.
- 13.2.7. Diabetology Ltd.
- 13.2.8. Generex Biotechnology Corp.
- 13.2.9. Novo Nordisk A/S
- 13.2.10. Oramed Pharmaceuticals Inc.
- 13.2.11. Pfizer Inc.
- 13.2.12. Proxima Concepts Limited (Diabetology Ltd.)
- 13.2.13. Sanofi
- 13.2.14. Synergy Pharmaceuticals Inc.
- 13.2.15. Tarsa Therapeutics Inc.
- List of Figures
- Figure 1: Global Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 2: Global Oral Proteins and Peptides Market by Drug Type, 2024
- Figure 3: Global Oral Proteins and Peptides Market by Product Type, 2024
- Figure 4: Global Oral Proteins and Peptides Market by Application, 2024
- Figure 5: Global Oral Proteins and Peptides Market by End User, 2024
- Figure 6: Global Oral Proteins and Peptides Market by Region, 2024
- Figure 7: Global Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 8: Global Oral Proteins and Peptides Market by Drug Type (in %), 2024 & 2034
- Figure 9: Global Linaclotide Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 10: Global Linaclotide Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 11: Global Plecanatide Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 12: Global Plecanatide Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 13: Global Calcitonin Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 14: Global Calcitonin Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 15: Global Insulin Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 16: Global Insulin Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 17: Global Octreotide Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 18: Global Octreotide Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 19: Global Oral Proteins and Peptides Market by Product Type (in %), 2024 & 2034
- Figure 20: Global Low Molecular Weight Iron Dextran Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 21: Global Low Molecular Weight Iron Dextran Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 22: Global Ferric Gluconate Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 23: Global Ferric Gluconate Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 24: Global Iron Sucrose Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 25: Global Iron Sucrose Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 26: Global Ferric Carboxyl Maltose Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 27: Global Ferric Carboxyl Maltose Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 28: Global Oral Proteins and Peptides Market by Application (in %), 2024 & 2034
- Figure 29: Global Gastric and Digestive Disorders Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 30: Global Gastric and Digestive Disorders Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 31: Global Bone Diseases Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 32: Global Bone Diseases Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 33: Global Diabetes Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 34: Global Diabetes Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 35: Global Hormonal Disorders Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 36: Global Hormonal Disorders Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 37: Global Other Applications Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 38: Global Other Applications Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 39: Global Oral Proteins and Peptides Market by End User (in %), 2024 & 2034
- Figure 40: Global Hospital Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 41: Global Hospital Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 42: Global Pharmaceutical Company Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 43: Global Pharmaceutical Company Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 44: Global Other End Users Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 45: Global Other End Users Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 46: Global Oral Proteins and Peptides Market by Region (in %), 2024 & 2034
- Figure 47: Europe Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 48: Europe Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 49: Europe Oral Proteins and Peptides Market by Country (in %), 2024 & 2034
- Figure 50: Germany Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 51: United Kingdom Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 52: France Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 53: Italy Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 54: Spain Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 55: Russia Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 56: Netherlands Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 57: North America Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 58: North America Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 59: North America Oral Proteins and Peptides Market by Country (in %), 2024 & 2034
- Figure 60: United States Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 61: Canada Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 62: Asia Pacific Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 63: Asia Pacific Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 64: Asia Pacific Oral Proteins and Peptides Market by Country (in %), 2024 & 2034
- Figure 65: China Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 66: Japan Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 67: India Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 68: South Korea Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 69: Australia Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 70: Indonesia Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 71: Latin America Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 72: Latin America Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 73: Latin America Oral Proteins and Peptides Market by Country (in %), 2024 & 2034
- Figure 74: Mexico Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 75: Brazil Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 76: Argentina Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 77: Middle East & Africa Oral Proteins and Peptides Market (in US$ Million), 2020-2024
- Figure 78: Middle East & Africa Oral Proteins and Peptides Market (in US$ Million), 2025-2034
- Figure 79: Middle East & Africa Oral Proteins and Peptides Market by Country (in %), 2024 & 2034
- Figure 80: Saudi Arabia Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 81: Turkey Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 82: Iran Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 83: UAE Oral Proteins and Peptides Market (in US$ Million), 2020-2034
- Figure 84: Market Value Chain
- List of Tables
- Table 1: Global Oral Proteins and Peptides Market Portraiture
- Table 2: Global Oral Proteins and Peptides Market by Drug Type (in US$ Million), 2024 & 2034
- Table 3: Global Oral Proteins and Peptides Market by Product Type (in US$ Million), 2024 & 2034
- Table 4: Global Oral Proteins and Peptides Market by Application (in US$ Million), 2024 & 2034
- Table 5: Global Oral Proteins and Peptides Market by End User (in US$ Million), 2024 & 2034
- Table 6: Global Oral Proteins and Peptides Market by Region (in US$ Million), 2024 & 2034
- Table 7: Europe Oral Proteins and Peptides Market by Country (in US$ Million), 2024 & 2034
- Table 8: North America Oral Proteins and Peptides Market by Country (in US$ Million), 2024 & 2034
- Table 9: Asia Pacific Oral Proteins and Peptides Market by Country (in US$ Million), 2024 & 2034
- Table 10: Latin America Oral Proteins and Peptides Market by Country (in US$ Million), 2024 & 2034
- Table 11: Middle East & Africa Oral Proteins and Peptides Market by Country (in US$ Million),
- 2024 & 2034
- Table 12: List of Key Players
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook